Clinical Trial Update: AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

The document describes an ongoing phase 2/3 trial comparing AX with AC as adjuvant therapy for node-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AC
• AX

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN